These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9473172)

  • 1. The clinical and economic rationale for peripheral blood progenitor cell transplantation. Introduction.
    Yee GC
    Pharmacotherapy; 1998; 18(1 Pt 2):1S-2S. PubMed ID: 9473172
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral blood progenitor cell transplantation: economic issues.
    Yee GC
    Pharmacotherapy; 1998; 18(1 Pt 2):9S-16S. PubMed ID: 9473174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
    Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
    Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic considerations in the use of peripheral blood progenitor cells to support high-dose chemotherapy.
    Glaspy JA
    Bone Marrow Transplant; 1999 May; 23 Suppl 2():S21-7. PubMed ID: 10335873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic evaluation of using granulocyte colony-stimulating factor after autologous peripheral blood progenitor cell transplantation in children.
    González-Vicent M; Madero L; Sevilla J; Díaz MA
    Haematologica; 2002 Jan; 87(1):105-6. PubMed ID: 11801471
    [No Abstract]   [Full Text] [Related]  

  • 6. Peripheral blood progenitor cell transplantation: impact on the pharmacy workload and budget.
    Davis TL
    Pharmacotherapy; 1998; 18(1 Pt 2):24S-29S. PubMed ID: 9473176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Economic evaluation of blood stem-cells autologous transplantation].
    Corroller AG; Fortanier C; Faucher C; Blaise D; Moatti JP
    Bull Cancer; 2001 Sep; 88(9):893-9. PubMed ID: 11604363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic costs of autologous hematopoietic progenitor cell transplantation].
    Manasanch L; Carreras E; Montserrat E
    Med Clin (Barc); 1997 Apr; 108(14):558. PubMed ID: 9190446
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous peripheral blood stem cell transplantation in childhood tumors.
    Kalmanti M; Stiakaki E
    Pediatr Hematol Oncol; 1999; 16(4):277-81. PubMed ID: 10407862
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues in peripheral blood stem cell transplantation.
    Lim HL; Lee SH
    Singapore Med J; 1998 Sep; 39(9):388-9. PubMed ID: 9885715
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphokines post autologous peripheral blood stem cell transplantation in children.
    Yaniv I
    Pediatr Hematol Oncol; 2000; 17(1):9-13. PubMed ID: 10689710
    [No Abstract]   [Full Text] [Related]  

  • 13. A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital.
    Kline RM; Meiman S; Tarantino MD; Herzig RH; Bertolone SJ
    Bone Marrow Transplant; 1998 Jan; 21(2):195-203. PubMed ID: 9489638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stem cells in hematology and oncology].
    Goldschmidt H; Egerer G; Fruehauf S; Ho AD
    Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation for pediatric solid tumors.
    Hale GA
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
    Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial.
    Bolwell BJ; Pohlman B; Andresen S; Kalaycio M; Goormastic M; Wise K; Wakeling A; Dannley R; Overmoyer B
    Bone Marrow Transplant; 1998 Feb; 21(4):369-73. PubMed ID: 9509971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplant of hematopoietic stem cells in childhood: where we are and where we are going.
    Locatelli F; Burgio GR
    Haematologica; 1998 Jun; 83(6):550-63. PubMed ID: 9676029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Duration of storage of autologous hematopoietic stem cell products for children and adolescents with malignant diseases].
    Dilloo D; Niemeyer C; Suttorp M; Vormoor J
    Klin Padiatr; 2005; 217(6):371-3. PubMed ID: 16307425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.